Frontotemporal Disorders Treatment Market 2021: Company Profiles, Trends, Industry Growth, Segments, Landscape - PowerPoint PPT Presentation

About This Presentation

Frontotemporal Disorders Treatment Market 2021: Company Profiles, Trends, Industry Growth, Segments, Landscape


Frontotemporal Disorders Treatment Market: Government Initiatives to Advance Neurological Disease Treatments Fuelling Revenue Growth: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028 – PowerPoint PPT presentation

Number of Views:40
Slides: 9
Provided by: Umesh213
Category: Other


Transcript and Presenter's Notes

Title: Frontotemporal Disorders Treatment Market 2021: Company Profiles, Trends, Industry Growth, Segments, Landscape


Vagus Nerve Stimulator Market Future Prospects
With Covid-19 Impact Analysis 2028 Growth
Research, Expert Review Forecast Report
  • May 2021

Report Id REP-GB-7759Published On
   2018-11-22Category Healthcare,
Pharmaceuticals Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Vagus Nerve Stimulator Market Analysis
Over three decades ago, it was discovered that
vagus nerve's intermittent electrical stimulation
develops a series of neural process inhibition,
which is responsible to alter the activities of
the brain and terminate seizures. This
investigation paved the way for development of a
device called vagus nerve stimulator. The neuro
stimulator device reduces the intensity and
frequency of seizures to almost half during the
management of refractory seizures. In a clinical
study, it has been found that after 48 hours of
stimulation of the vagus nerve, vagus nerve
stimulator can promote neurogenesis in the
dentate gyrus of rat hippocampus. Recent studies
have proved the effectiveness of vagus nerve
stimulator in management of obesity in patients
with depression. Vagus nerve stimulator has also
gained significant popularity with positive
results in epilepsy surgery and
treatment-resistant depression. According to the
latest research by the company, the global vagus
nerve stimulator market is projected to account
for over US 1.129.5 Mn, in terms of value, by
2028 end. The report on the global vagus nerve
stimulator market is expected to witness
significant growth potential with an average
Y-o-Y growth rate pegged at 10.6 through
2028. Over the years, the burden of neurological
diseases is increasing in the emerging countries.
This has increased the usage of implantable vagus
nerve stimulator in neurological patients, since
its inception in 2005. The WHO estimates that
neurological disorders are responsible for
4.5-11 of all illnesses in low- and high-income
economies. This prevalence is relatively high as
compared to cancer, respiratory and
gastrointestinal disorders. It is expected that
the disease burden is expected to increase
further over the forecast period. In addition,
neurological disorders contributed to 92 million
disability-adjusted life-years in 2005 and are
projected to be 103 million in 2030 worldwide.
Vagus Nerve Stimulator Market Analysis
The vagus nerve stimulator implanted devices are
currently being approved for the treatment of
refractory epilepsy and depression only. However,
results from many ongoing clinical studies are in
pipeline, awaiting to notify about the
appropriate use of vagus nerve stimulator devices
in other applications. The market for vagus nerve
stimulator is expected to grow significantly due
to favorable reimbursement policies in the
developed countries. As per the Center for
Medicare Medicaid Services database, many vagus
nerve stimulator devices are covered under the
reimbursement criteria. Besides, many health
systems are also putting in efforts to provide
these products at affordable prices.
Manufacturers are investing in their products so
as to meet the expectations of the end users. As
implantable devices are associated with possible
epileptic side-effects, a paradigm shift towards
increase in demand for external vagus nerve
stimulator devices is witnessed in the recent
years. Additionally, the external vagus nerve
stimulator is more effective in terms of
treatment as well as affordable for the
patients. A sample of this report is available
upon request _at_ https//
Vagus Nerve Stimulator Market Analysis
Macroeconomic indicators such as increasing
healthcare expenditure and prioritizing service
quality will increase the adoption of quality
equipment and consequently drive the growth of
the global vagus nerve stimulator market.
According the current GDP forecast report by IMF,
healthcare spending will increase by 6
Y-o-Y. On the grey side, the use of implantable
vagus nerve stimulators is associated with major
complications, for instance, occurrence of
cardiac dysrhythmias both at the time of
implantation as well as post-operative
implantation. After examining the effects in 130
patients implanted with a vagus nerve stimulators
between 2000 and 2013, it was observed that there
is an increased response rate from 22.1 to 43.8
from the first to fifth year of vagus nerve
stimulators implantation. Though the functional
anatomy and physiology of the left and right
vagus nerve is consistent, the cause of this
complication remains uncertain Preview Analysis
On Vagus Nerve Stimulator Market Manufacturers
Launching Non-invasive Products to Gain
Competitive Edge Global Industry Analysis 2013 -
2017 and Opportunity Assessment 2018 -
2028 https//
Vagus Nerve Stimulator Market Analysis
The report offers a comprehensive taxonomy of
vagus nerve stimulator market based on product
type, end user, application type and region.
Based on product type, the vagus nerve stimulator
market is segmented into implantable and
noninvasive (tVNS) based. According to the
company, the implantable segment accounted for
over 99.3 revenue share in the global vagus
nerve stimulator market in 2017. However, the
growing popularity of noninvasive ones (vagal
nerve stimulator) might limit the segment's
growth in the near future. The vagus nerve
stimulator finds application in pain management,
epileptic seizures, obesity, depression and
anxiety. By application, epileptic seizures is
projected to be the major application segment in
terms of revenue in the global vagus nerve
stimulators market. These vagus nerve stimulators
are used by hospitals, ambulatory surgical
centers, specialty clinics and home care
settings. The vagus nerve stimulator market has
been analysed across regions of North
America, Latin America, Europe, Asia Pacific
Excluding Japan, Japan and MEA. Asia Pacific is
expected to be the most lucrative regional market
for vagus nerve stimulator during the forecast
period. The report tracks some of the key
companies operating in the global vagus nerve
stimulator market, including ElectroCore LivaNova
LLC, Cerbomed GmbH, ReShape Lifesciences, Inc.
NERVANA LLC, ReShape Lifesciences, Inc. Beijing
PINS Medical Co., Ltd, Parasym Health, etc.
To know more about us, please visit our website For sales queries
or new topics email us on sales_at_futuremarketinsi For media queries, contact the press
office at For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
Write a Comment
User Comments (0)